Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,610.23
(
-0.22%
)
US TECH 100
23,742.40
(
-0.23%
)
Dow Jones
46,091.51
(
-0.29%
)
Brent Oil
103.48
(
-2.91%
)
Bitcoin
70,394.61
(
-1.19%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

dewophile

Send PM Follow Ignore
Followers 49
Posts 5519
Boards Moderated 0
Alias Born 07/19/2006

dewophile

Re: DewDiligence post# 66998

Sunday, 10/05/2008 9:26:15 PM

Sunday, October 05, 2008 9:26:15 PM

Post# of 257259
because interferon is likely to have better efficacy against viral strains resistant to polymerase and protease inhibitors
besides - how many oral agents and proven combinations do you think will be approved before IN-lambda makes it to market?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today